Lawsuit Alleges That Regular Zantac Use Led To Stomach Cancer
A case filed in federal court in Missouri claimed that a Missouri man was diagnosed with stomach and esophageal cancer due to regular use of Zantac (ranitidine). The complaint said the people had been taking Zantac regularly for about 20 years and was diagnosed with esophageal and stomach cancer.
The complaint alleges that the cancer was caused by exposure to N-nitrosodimethylamine (NDMA) in Zantac and names a number of defendants, including Boehringer Ingelheim Pharmaceuticals. , Sanofi-Aventis, Chattem, Pfizer, and GlaxoSmithKline.
The complaint describes NDMA as a potent carcinogen used in laboratory tests to induce tumors in animals. Its function is only to cause cancer. It is toxic to humans too. If you are also one of them then you can also file a stomach cancer lawsuit via https://www.zantacantacidcancerlawsuit.com/stomach-cancer-lawsuits.asp against the drug manufacturer. The FDA has requested that all products containing ranitidine be withdrawn from the US market by April 1, 2020.
Image Source: Google
NDMA and cancer:
The complaint states that NDMA is “a member of the N-nitrosamine, a powerful carcinogen family” and the danger to humans “has long been recognized”. The complaint states that a 1979 news report found that “NDMA has caused cancer in nearly every laboratory animal tested so far”.
According to the lawsuit, NDMA has been classified as a potential human carcinogen by the EPA and IARC, and the World Health Organization adds that scientific tests have shown that NDMA has been linked to colon or stomach cancer.
The complaint alleges that in the early 1980s, manufacturers recalled products containing harmful levels of NDMA, meaning that the defendant knew, or should have known, that NDMA was harmful. This case demonstrates that animal researches have shown that verbally authorized NDMA is becoming the reason for causing cancer of the liver, stomach, kidney, pancreas, bladder, and other organs.